-
Loading metrics
High-Throughput Screening Identifies Idarubicin as a Preferential Inhibitor of Smooth Muscle versus Endothelial Cell Proliferation
- Shakti A. Goel,
- Lian-Wang Guo,
- Bowen Wang,
- Song Guo,
- Drew Roenneburg,
- Gene E. Ananiev,
- F. Michael Hoffmann,
- K. Craig Kent
x
- Published: February 24, 2014
- https://doi.org/10.1371/journal.pone.0089349